Evaluate Novel and Emerging PTSD Treatments Phase II
The overarching goal is to test the feasibility of conducting a randomized controlled trial of the novel treatment compared to treatment as usual in a sample of serving CAF members or Veterans with PTSD. This will include:
- Identifying optimal inclusion and exclusion criteria.
- Identify effective recruitment strategies.
- Measure potential adverse outcomes including premature treatment discontinuation.
- Collect outcomes data to enable sample size calculations for definitive study.
Since it is only through hearing from Indigenous peoples and their experiences with the military health care system that the CAF can make improvements, this funding call seeks submissions that use qualitiative methods (i.e., interviews, qualitative surveys, case studies, etc.).
